InxMed

Nanjing, China · In IPO Registration

Developer of cancer therapeutics designed to treat cancer. InxMed is based in Nanjing, China. Its last reported valuation was $306 million in Aug 2025. It has raised $132 million.

Last reported valuation
$306.0M
Oct 2026
Priced at
—
Total raised
$131.6M
Last round
—

Who backs InxMed?

11 investors
InvestorType
CMG SDIC FundVenture capital
Proxima Ventures (China)Venture capital
Ennovation VenturesOther
Shaaxi Shantou CapitalOther
Shaanxi Growth Enterprise Guide FundOther
AIHC Capital—
Fosun Health Capital—
HosenCare Brothers—
Hyfinity Investments—
Kunnuo Tianqin Venture Capital—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

InxMed investors

11 investors are on record for InxMed, including CMG SDIC Fund, Proxima Ventures (China), Ennovation Ventures and Shaaxi Shantou Capital.

Free account
More of InxMed with a free account
  • ·The complete investor list: 11 names
  • ·Watch InxMed: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like InxMed. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View